Skip to Main Content
Services Talent Knowledge
Site Search


Our attorneys stay on top of changes in legislation, agency regulations, case law, and industry trends—then craft timely legal alerts to keep clients up to date on legal developments important to their business.

December 16, 2021

Post-Brexit Update: Is Your Medical Device Ready for Great Britain in 2022?

Following Great Britain’s exit from the European Union, there have been a number of changes to how medical devices are placed in the Great Britain market, which includes England, Wales, and Scotland (but not Northern Ireland). Medical device manufacturers and distributors need to be aware of these changes and must take certain steps to ensure compliance with the changing requirements.

The following dates and regulatory changes are notable for medical device manufacturers and distributors operating in Great Britain:

  • As of January 1, 2021, all medical devices placed on the Great Britain market were required to be registered with the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA). All grace periods for registering medical devices have since passed with the exception of Class I Medical Devices, custom-made devices, general in vitro diagnostic products (IVDs), and systems and procedure packs.  Accordingly, all Class I Medical Devices must be registered with the MHRA by January 1, 2022.
  • Medical device manufacturers based outside of the United Kingdom with no local presence are now required to appoint a United Kingdom Responsible Person (UKRP) who will take responsibility for the product in Great Britain. The UKRP is responsible for managing medical device registration as well as any relevant importer relationships and liaising with the MHRA on the manufacturer’s behalf.
  • The European Union’s CE marking will continue to be recognized in Great Britain until June 30, 2023. On July 1, 2023, and thereafter, medical devices are required to be labeled with a United Kingdom Conformity Assessed (UKCA) mark. Notably, prior to July 1, 2023, manufacturers may use the UKCA mark on a voluntary basis, and medical devices can have both marks present on labeling. Dual marking will continue to be accepted after the July 1, 2023, deadline.
  • Certificates issued by Notified Bodies recognized by the European Union will continue to be valid for the Great Britain market until June 30, 2023. The European Union will no longer recognize United Kingdom Notified Bodies.
  • The name and address of the UKRP must be included on product labeling where the UKCA mark has been affixed. This includes instances where medical devices are dually marked.

To ensure compliance with these post-Brexit requirements, medical device manufacturers and distributors must ensure that the UKCA mark is affixed to all devices placed on the Great Britain market by July 1, 2023, as well as ensure that the name and address of the UKRP is included on the labeling. Additionally, manufacturers and distributors must ensure that a UKRP is appointed and that all medical devices are appropriately registered with the United Kingdom’s MHRA. Barclay Damon’s Health & Human Services Providers Team has experience assisting medical device manufacturers with compliance obligations as well as conducting due diligence relating to health care transactions involving medical device manufacturers, including those with an international presence.

If you have any questions regarding the content of this alert, please contact Brad Gallagher, partner, at; Jamie Dughi Hogenkamp, associate, at; Dena DeFazio, associate, at; or another member of the firm’s Health & Human Services Providers Team.

Featured Media


COVID-19 Business Interruption Update: New York High Court Affirms in Favor of Insurer


USFWS Introduces General Permit for Bald and Golden Eagle Incidental Take


ORES Executive Director Issues First Denial of Section 94-C Permit Application Following Applicant's Partial Loss of Site Control


New Details About OPWDD Spending in the New York State FY 2025 Executive Budget


Second Circuit Reverses in Favor of Insured in $600,000 Fire Loss Case


New York State Minimum Wage Increases Are Here: Are You Compliant?

We're Growing in DC!

We’re excited to announce Barclay Damon’s combination with Washington DC–based Shapiro, Lifschitz & Schram. SLS’s 10 lawyers, three paralegals, and four administrative staff will join Barclay Damon while maintaining their current office in DC’s central business district. Our clients will benefit from SLS’s corporate, real estate, finance, and construction litigation experience and national energy-industry profile, and their clients from our full range of services.

Read More

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out